Danny Rischin

De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies.

Hisham Mehanna, Danny Rischin, Stuart J Wong, Vincent Gregoire, Robert Ferris, John Waldron, Quynh-Thu Le, Martin Forster, Maura Gillison, Sarbani Laskar, Makoto Tahara, Amanda Psyrri, Jan Vermorken, Sandro Porceddu

Journal article  |  2020  |  Journal of Clinical Oncology

Human papillomavirus (HPV)-positive oropharyngeal cancer (OPC) is increasing rapidly. The younger age, significantly improved prog..

Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the Delivery of Postoperative Radiation Therapy in Complex Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN).

Sandro V Porceddu, Christopher Daniels, Sue S Yom, Howard Liu, John Waldron, Vincent Gregoire, Alisha Moore, Michael Veness, Min Yao, Jorgen Johansen, Hisham Mehanna, Danny Rischin, Quynh-Thu Le

Journal article  |  2020  |  International Journal of Radiation Oncology*Biology*Physics

Radiation therapy (RT) consensus contouring guidelines in the postoperative setting for complex cutaneous squamous cell carcinoma ..

Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy

Jason Toppi, Yik Seng Tham, Angela Webb, Michael A Henderson, Danny Rischin, Matthew JR Magarey

Journal article  |  2020  |  ANZ Journal of Surgery

BACKGROUND: Surgery is the primary treatment for patients with recurrent head and neck cutaneous squamous cell carcinoma (cSCC) wh..

Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus

Hisham Mehanna, John C Hardman, Jared A Shenson, Ahmad K Abou-Foul, Michael C Topf, Mohammad AlFalasi, Jason YK Chan, Pankaj Chaturvedi, Velda Ling Yu Chow, Andreas Dietz, Johannes J Fagan, Christian Godballe, Wojciech Golusinski, Akihiro Homma, Sefik Hosal, N Gopalakrishna Iyer, Cyrus Kerawala, Yoon Woo Koh, Anna Konney, Luiz P Kowalski, et al.

Journal article  |  2020  |  The Lancet Oncology

The speed and scale of the global COVID-19 pandemic has resulted in unprecedented pressures on health services worldwide, requirin..

Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors

Lachlan McDowell, June Corry, Jolie Ringash, Danny Rischin

Journal article  |  2020  |  Frontiers in Oncology

Concerted research efforts over the last three decades have resulted in improved survival and outcomes for patients diagnosed with..

Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412.

Jean-Pascal Machiels, Yungan Tao, Barbara Burtness, Makoto Tahara, Lisa Licitra, Danny Rischin, John Waldron, Christian Simon, Vincent Gregoire, Kevin Harrington, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Yoann Pointreau, Brett G M Hughes, Sercan Aksoy, Marcin Hetnal, Joy Y Ge, Holly Brown, Jonathan Cheng, Behzad Bidadi, et al.

Journal article  |  2020  |  Future Oncology

Current treatment guidelines for patients with locally advanced head and neck squamous cell carcinoma (HNSCC) recommend multimodal..

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing.

Danny Rischin, Michael R Migden, Annette M Lim, Chrysalyne D Schmults, Nikhil I Khushalani, Brett GM Hughes, Dirk Schadendorf, Lara A Dunn, Leonel Hernandez-Aya, Anne Lynn S Chang, Badri Modi, Axel Hauschild, Claas Ulrich, Thomas Eigentler, Brian Stein, Anna C Pavlick, Jessica L Geiger, Ralf Gutzmer, Murad Alam, Emmanuel Okoye, et al.

Journal article  |  2020  |  Journal for ImmunoTherapy of Cancer

BACKGROUND: Cemiplimab, a high-affinity, potent human immunoglobulin G4 monoclonal antibody to programmed cell death-1 demonstrate..

Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care

Luke McLean, James R Whittle, Jonathan Graham, Huda Ismail, Meir Lichtenstein, Rodney J Hicks, Orla McNally, Alan Herschtal, Mark Rosenthal, Danny Rischin, Anne Hamilton

Journal article  |  2020  |  Gynecologic Oncology

BACKGROUND: Glomerular filtration rate (GFR) measured by Chromium-51-EDTA excretion (51Cr-GFR) is considered the gold standard of ..

Prognostic gene expression signature for high-grade serous ovarian cancer.

J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, MP Intermaggio, HS Leong, S Chen, W Elatre, B Gilks, T Nazeran, M Volchek, RC Bentley, C Wang, DS Chiu, S Kommoss, SCY Leung, J Senz, A Lum, V Chow, et al.

Journal article  |  2020  |  Annals of Oncology

BACKGROUND: Median overall survival (OS) for women with high-grade serous ovarian cancer (HGSOC) is ∼4 years, yet survival varies ..

Burden and clinical outcomes of hospital-coded infections in patients with cancer: an 11-year longitudinal cohort study at an Australian cancer centre

Jake C Valentine, Lisa Hall, Tim Spelman, Karin M Verspoor, John F Seymour, Danny Rischin, Karin A Thursky, Monica A Slavin, Leon J Worth

Journal article  |  2020  |  Supportive Care in Cancer

PURPOSE: Patients with cancer are at increased risk for infection, but the relative morbidity and mortality of all infections is n..

Patient-reported quality of life and toxicity in unilateral and bilateral radiotherapy for early-stage human papillomavirus associated tonsillar carcinoma

Lachlan McDowell, Georgina Casswell, Mathias Bressel, Karla Gough, Allison Drosdowsky, Andrew Coleman, Sudi Shrestha, Ieta D'Costa, Tsien Fua, Albert Tiong, Chen Liu, Sweet Ping Ng, Benjamin Solomon, Danny Rischin

Journal article  |  2020  |  Clinical and Translational Radiation Oncology

Inducible T cell co-stimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and combination with pembrolizumab: Preliminary results from INDUCE-1 expansion cohorts in head and neck squamous cell carcinoma (HNSCC)

C Le Tourneau, D Rischin, S Groenland, A Lim, J Martin-Liberal, V Moreno, JM Trigo, M Mathew, D Cho, A Hansen, D Vincente Baz, M Maio, A Italiano, J Bauman, M Chisamore, H Zhou, C Ellis, M Ballas, A Hoos, E Angevin

Conference Proceedings  |  2020  |  Annals of Oncology

Pharmacokinetic/pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

E Angevin, S Groenland, T Bauer, D Rischin, I Gardeazabal, V Moreno, JM Trigo, M Chisamore, J Shaik, F Rigat, C Ellis, H Chen, R Gagnon, SJ Scherer, D Turner, S Yadavilli, M Ballas, A Hoos, M Maio

Conference Proceedings  |  2020  |  Annals of Oncology

Outcomes of curative (chemo)radiotherapy for patients with non-p16 positive head and neck squamous cell carcinoma who are borderline for curative treatment

Daniel Xing, Albert Tiong, Mathias Bressel, Danny Rischin, Phillip Tran, June Corry

Journal article  |  2020  |  Journal of Medical Imaging and Radiation Oncology

INTRODUCTION: Appropriate selection of head and neck squamous cell cancer (HNSCC) patients for curative treatment is difficult, an..

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

Michael R Migden, Nikhil I Khushalani, Anne Lynn S Chang, Karl D Lewis, Chrysalyne D Schmults, Leonel Hernandez-Aya, Friedegund Meier, Dirk Schadendorf, Alexander Guminski, Axel Hauschild, Deborah J Wong, Gregory A Daniels, Carola Berking, Vladimir Jankovic, Elizabeth Stankevich, Jocelyn Booth, Siyu Li, David M Weinreich, George D Yancopoulos, Israel Lowy, et al.

Journal article  |  2020  |  The Lancet Oncology

BACKGROUND: Cemiplimab has shown substantial antitumour activity in patients with metastatic cutaneous squamous cell carcinoma. Pa..

Validation and characterisation of prognostically significant PD-L1( ) immune cells in HPV plus oropharyngeal squamous cell carcinoma

Richard J Young, Mathias Bressel, Sandro Porceddu, Janez Cernelc, Peter Savas, Howard Liu, Damien Urban, Alesha A Thai, Caroline Cooper, Tsien Fua, Paul Neeson, Danny Rischin, Benjamin Solomon

Journal article  |  2020  |  Oral Oncology

We previously showed in human papillomavirus positive oropharyngeal squamous cell carcinoma (HPV+OPSCC) that the presence of intra..

Impact of prior lines of systemic therapy (PST) on the efficacy of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC)

D Rischin, NI Khushalani, CD Schmults, A Guminski, ALS Chang, KD Lewis, AM Lim, L Hernandez-Aya, BGM Hughes, D Schadendorf, A Hauschild, E Stankevich, J Booth, S Li, Z Chen, J Desai, I Lowy, MG Fury, MR Migden

Conference Proceedings  |  2019  |  ANNALS OF ONCOLOGY

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J Harrington, Richard Greil, Denis Soulieres, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Baste, Prakash Neupane, Ase Bratland, Thorsten Fuereder, Brett GM Hughes, Ricard Mesia, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Ruey-Long Hong, Rene Gonzalez Mendoza, Ananya Roy, Yayan Zhang, et al.

Journal article  |  2019  |  The Lancet

BACKGROUND: Pembrolizumab is active in head and neck squamous cell carcinoma (HNSCC), with programmed cell death ligand 1 (PD-L1) ..

Disparities starting adjuvant chemotherapy for locally advanced cervical cancer in the international, academic, randomised, phase 3 OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)

Linda Mileshkin, Elizabeth Barnes, Kathleen Moore, Val Gebski, Madeleine King, Kailash Narayan, Ilka Kolodziej, Katrin Sjoquist, Anthony Fyles, William Small, David Gaffney, Michael Quinn, John Andrews, Spencer Thompson, Warner Huh, David Miller, Paul Silvestro, Danny Rischin, Martin Stockler, Bradley Monk

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103 immune cell abundance.

B Solomon, RJ Young, M Bressel, J Cernelc, P Savas, H Liu, D Urban, A Thai, C Cooper, T Fua, P Neeson, S Loi, SV Porceddu, D Rischin

Journal article  |  2019  |  Annals of oncology : official journal of the European Society for Medical Oncology

BACKGROUND: Accurate prognostic stratification of human papillomavirus-associated oropharyngeal cancers (HPV+OPSCC) is required to..

A phase III, randomised, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation in patients with high-risk cutaneous squamous cell carcinoma (CSCC)

D Rischin, MG Fury, I Lowy, E Stankevich, S Li, H Han, SV Porceddu

Conference Proceedings  |  2019  |  ANNALS OF ONCOLOGY

Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti-PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)

D Rischin, AM Lim, CD Schmults, NI Khushalani, BG Hughes, D Schadendorf, LA Dunn, ALS Chang, A Hauschild, C Ulrich, T Eigentler, MR Migden, AC Pavlick, J Geiger, E Stankevich, S Li, I Lowy, MG Fury, A Guminski

Conference Proceedings  |  2019  |  ANNALS OF ONCOLOGY

Inducible T cell costimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and in combination with pembrolizumab (pembro): Preliminary results from INDUCE-1 expansion cohorts (EC) in head and neck squamous cell carcinoma (HNSCC)

D Rischin, SL Groenland, AML Lim, J Martin-Liberal, V Moreno, JM Trigo Perez, C Le Tourneau, M Mathew, DC Cho, AR Hansen, D Vincente-Baz, M Maio, A Italiano, JR Bauman, M Chisamore, H Zhou, C Ellis, M Ballas, A Hoos, E Angevin

Conference Proceedings  |  2019  |  ANNALS OF ONCOLOGY

Pharmacokinetic/ pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

M Maio, SL Groenland, T Bauer, D Rischin, I Gardeazabal, V Moreno, JM Trigo Perez, M Chisamore, J Sadik Shaik, F Rigat, C Ellis, H Chen, R Gagnon, S Scherer, D Turner, S Yadavilli, M Ballas, A Hoos, E Angevin

Conference Proceedings  |  2019  |  ANNALS OF ONCOLOGY

Cemiplimab, a human monoclonal antibody to PD-1, in patients with advanced cutaneous squamous cell carcinoma (CSCC): Clinical experience from the phase 1 and phase 2 studies

Michael R Migden, Alexander Guminski, Karl D Lewis, Nikhil I Khushalani, Kyriakos P Papadopoulos, Yamini Patel, Michael Andria, Matthew G Fury, Danny Rischin

Conference Proceedings  |  2019  |  JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Disparities starting adjuvant chemotherapy for locally advanced cervix cancer in the international, academic, randomised, phase III OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)

L Mileshkin, E Barnes, KN Moore, V Gebski, M King, K Narayan, IK Kolodziej, K Sjoquist, A Fyles, W Small, D Gaffney, M Quinn, J Andrews, S Thompson, W Huh, M Carlson, PA Disilvestro, D Rischin, MR Stockler, BJ Monk

Conference Proceedings  |  2019  |  ANNALS OF ONCOLOGY

Pharmacokinetic (PK) analysis of weight-based and fixed dose cemiplimab in patients (pts) with advanced malignancies

MR Migden, A Paccaly, KP Papadopoulos, F Yang, JD Davis, R Rippley, I Lowy, MG Fury, E Stankevich, D Rischin

Conference Proceedings  |  2019  |  ANNALS OF ONCOLOGY

Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103( ) immune cell abundance

B Solomon, RJ Young, M Bressel, J Cernelc, P Savas, H Liu, D Urban, A Thai, C Cooper, T Fua, P Neeson, S Loi, SV Porceddu, D Rischin

Journal article  |  2019  |  Annals of Oncology

BACKGROUND: Accurate prognostic stratification of human papillomavirus-associated oropharyngeal cancers (HPV+OPSCC) is required to..

Radiation oncology outpatient medication management needs and service gaps - A cross-sectional study of patients and clinicians

Sam Maleki, Marliese Alexander, Chen Liu, Danny Rischin, Senthil Lingaratnam, Tsien Fua

Journal article  |  2019  |  Journal of Oncology Pharmacy Practice

Sexual Satisfaction and Relationship Status in Long-term Survivors of Human Papillomavirus-Associated Oropharyngeal Carcinoma

G Casswell, K Gough, A Drosdowsky, M Bressel, S Shrestha, A Coleman, D Rischin, I D'Costa, T Fua, AC Tiong, C Liu, B Solomon, LJ McDowell

Conference Proceedings  |  2019  |  International Journal of Radiation Oncology*Biology*Physics

Cemiplimab, a human monoclonal PD-1 Antibody, in Patients with advanced cutaneous Squamous Cell Carcinoma (adcSCC): Clinical Experience from Phase-1 and Phase-2 Studies

M Migden, A Guminski, K Lewis, N Khushalani, K Papadopoulos, Y Patel, M Andria, M Fury, D Rischin

Conference Proceedings  |  2019  |  JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Clinical Utility of Real-Time Targeted Molecular Profiling in the Clinical Management of Ovarian Cancer: The ALLOCATE Study

Olga Kondrashova, Gwo-Yaw Ho, George Au-Yeung, Leakhena Leas, Tiffany Boughtwood, Kathryn Alsop, Giada Zapparoli, Alexander Dobrovic, Yi-An Ko, Arthur L Hsu, Clare J Love, Sebastian Lunke, Matthew J Wakefield, Orla McNally, Michael Quinn, Sumitra Ananda, Deborah Neesham, Anne Hamilton, Marisa Grossi, Alison Freimund, et al.

Journal article  |  2019  |  JCO Precision Oncology

Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up.

Alexander David Guminski, Annette May Ling Lim, Nikhil I Khushalani, Chrysalyne D Schmults, Leonel Fernando Hernandez-Aya, Badri Modi, Lara Dunn, Brett Gordon Maxwell Hughes, Anne Lynn S Chang, Axel Hauschild, Michael Robert Migden, Ralf Gutzmer, Murad Alam, Vladimir Jankovic, Elizabeth Stankevich, Jocelyn Booth, Siyu Li, Israel Lowy, Matthew G Fury, Danny Rischin

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Primary analysis of phase 2 results of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with locally advanced cutaneous squamous cell carcinoma (IaCSCC).

Michael Robert Migden, Nikhil I Khushalani, Anne Lynn S Chang, Danny Rischin, Chrysalyne D Schmults, Leonel Fernando Hernandez-Aya, Friedegund Elke Meier, Dirk Schadendorf, Alexander David Guminski, Axel Hauschild, Deborah JL Wong, Gregory A Daniels, Carola Berking, Vladimir Jankovic, Elizabeth Stankevich, Jocelyn Booth, Siyu Li, Israel Lowy, Matthew G Fury, Karl D Lewis

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).

Danny Rischin, Kevin J Harrington, Richard Greil, Denis Soulieres, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Baste, Prakash C Neupane, Ase Bratland, Thorsten Fuereder, Brett Gordon Maxwell Hughes, Ricard Mesia, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Yayan Zhang, Fan Jin, Burak Gumuscu, Barbara Burtness

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Interim analysis of phase 2 results for Cemiplimab, a human monoclonal antibody to programmed death-1 (PD-1), in patients with locally advanced cutaneous squamous cell carcinoma

MR Migden, C Berking, ALS Chang, TK Eigentler, A Hauschild, L Hernandez-Aya, N Khushalani, KD Lewis, F Meier, B Modi, D Rischin, D Schadendorf, CD Schmults, C Ulrich, J Booth, S Li, K Mohan, E Stankevich, I Lowy, MG Fury

Conference Proceedings  |  2019  |  JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

A clinical trial with protracted infusion 5-fluorouracil and mitomycin C for localized squamous cell carcinoma of the anus

David Ngan, Julie Chu, Sarat Chander, Michael Michael, Alexander G Heriot, Samuel Y Ngan, Danny Rischin, Trevor Leong

Journal article  |  2019  |  Asia-Pacific Journal of Clinical Oncology

Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)

Kristina Lindemann, Philip J Beale, Emma Rossi, Jeff C Goh, Michelle M Vaughan, Meaghan E Tenney, Julie K Martyn, Dirkje Sommeijer, Jose L Iglesias, Gabriel Kremmidiotis, Jeremy Simpson, Elizabeth Doolin, Tina C Lavranos, Annabell Leske, Anneso S Veillard, David Espinoza, Martin R Stockler, Danny Rischin

Journal article  |  2019  |  Cancer Chemotherapy and Pharmacology

A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies

Sam Maleki, Marliese Alexander, Tsien Fua, Chen Liu, Danny Rischin, Senthil Lingaratnam

Journal article  |  2019  |  JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Phase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC)

HM Babiker, I Brana, D Mahadevan, TK Owonikoko, E Calvo, D Rischin, V Moreno, KP Papadopoulos, M Crittenden, S Formenti, J Giralt, P Garrido, A Hervas Moron, KK Mohan, MG Fury, I Lowy, E Stankevich, M Feng, J Li, M Mathias

Conference Proceedings  |  2018  |  ANNALS OF ONCOLOGY

Cemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts

D Rischin, M Gil-Martin, A Gonzalez-Martin, I Brana, JY Hou, D Cho, G Falchook, S Formenti, S Jabbour, K Moore, A Naing, KP Papadopoulos, J Baranda, A Weise, MG Fury, M Feng, J Li, I Lowy, M Mathias

Conference Proceedings  |  2018  |  ANNALS OF ONCOLOGY

Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series

Emma L Mitchell, Peter Kar Han Lau, Chloe Khoo, David Liew, Jessica Leung, Bonnia Liu, Adam Rischin, Albert G Frauman, Damien Kee, Kortnye Smith, Benjamin Brady, Danny Rischin, Andrew Gibson, Linda Mileshkin, Oliver Klein, Andrew Weickhardt, Surein Arulananda, Mark Shackleton, Grant McArthur, Andrew Ostor, et al.

Journal article  |  2018  |  European Journal of Cancer

Non-smoking, non-drinking elderly females, a 5 year follow-up of a clinically distinct cohort of oral squamous cell carcinoma patients

Adrian DeAngelis, Omar Breik, Kendrick Koo, Tim Iseli, Alf Nastri, Tsien Fua, Danny Rischin, Michael McCullough, David Wiesenfeld

Journal article  |  2018  |  Oral Oncology

GOG 3016/ENGOT-cx9: An open-label, multi-national, randomized, phase III trial of cemiplimab, an anti-PD-1, versus investigator's choice (IC) chemotherapy in >= second-line recurrent or metastatic cervical cancer

KS Tewari, I Vergote, A Oaknin, E Alvarez, S Gaillard, S Lheureux, D Rischin, AD Santin, M Feng, M Mathias, M Fury, I Lowy, BJ Monk

Conference Proceedings  |  2018  |  Annals of Oncology

Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline

Carole Fakhry, Christina Lacchetti, Lisa M Rooper, Richard C Jordan, Danny Rischin, Erich M Sturgis, Diana Bell, Mark W Lingen, Seema Harichand-Herdt, John Thibo, Jose Zevallos, Bayardo Perez-Ordonez

Journal article  |  2018  |  Journal of Clinical Oncology

Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCM (TM) system in a quaternary oncology centre

Michael Moloney, David Faulkner, Emma Link, Danny Rischin, Ben Solomon, Annette M Lim, John R Zalcberg, Michael Jefford, Michael Michael

Journal article  |  2018  |  Cancer Chemotherapy and Pharmacology

Phase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC)

HM Babiker, I Brana, D Mahadevan, TK Owonikoko, E Calvo, D Rischin, V Moreno, KP Papadopoulos, M Crittenden, S Formenti, J Giralt, P Garrido Lopez, A Hervas Moron, KK Mohan, MG Fury, I Lowy, E Stankevich, M Feng, J Li, M Mathias

Conference Proceedings  |  2018  |  Annals of Oncology

First in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1

A Hansen, TM Bauer, V Moreno, M Maio, S Groenland, J Martin-Liberal, H Gan, D Rischin, M Millward, AJ Olszanski, DC Cho, E Paul, M Ballas, C Ellis, H Zhou, S Yadavilli, J Sadik Shaik, EV Schmidt, A Hoos, E Angevin

Conference Proceedings  |  2018  |  Annals of Oncology

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

B Burtness, KJ Harrington, R Greil, D Soulieres, M Tahara, G De Castro, A Psyrri, N Baste Rotllan, PC Neupane, A Bratland, T Fuereder, BGM Hughes, R Mesia, N Ngamphaiboon, T Rordorf, WZ Wan Ishak, A Roy, J Cheng, F Jin, D Rischin

Conference Proceedings  |  2018  |  Annals of Oncology

Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments

Benjamin Solomon, Richard J Young, Danny Rischin

Journal article  |  2018  |  Seminars in Cancer Biology

KEYNOTE-412: Phase III study of pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma (HNSCC)

J-P Machiels, L Licitra, YG Tao, C-J Yen, D Rischin, JN Waldron, BA Burtness, V Gregoire, SS Agarwala, J Yorio, J-P Delord, S Aksoy, S Ikeda, R-L Hong, JY Ge, H Brown, B Bidadi, LL Siu

Conference Proceedings  |  2018  |  ANNALS OF ONCOLOGY

Cemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts

D Rischin, M Gil-Martin, A Gonzalez-Martin, I Brana, JY Hou, D Cho, GS Falchook, S Formenti, S Jabbour, K Moore, A Naing, KP Papadopoulos, J Baranda, A Weise, MG Fury, M Feng, J Li, I Lowy, M Mathias

Conference Proceedings  |  2018  |  Annals of Oncology

Diabetes associated with immune checkpoint inhibition: presentation and management challenges

A Galligan, W Xu, S Fourlanos, A Nankervis, C Chiang, AM Mant, P Parente, D Rischin, B Krishnamurthy, S Sandhu, PG Colman

Journal article  |  2018  |  Diabetic Medicine

Unilateral Radiotherapy Treatment for p16/Human Papillomavirus-Positive Squamous Cell Carcinoma of Unknown Primary in the Head and Neck

Albert Tiong, Danny Rischin, Richard J Young, Alan Herschtal, Ben Solomon, Ieta D'Costa, Tsien Fua, Chen Liu, Andrew Coleman, Stephen Kleid, Benjamin J Dixon, June Corry

Journal article  |  2018  |  The Laryngoscope

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

MR Migden, D Rischin, CD Schmults, A Guminski, A Hauschild, KD Lewis, CH Chung, L Hernandez-Aya, AM Lim, ALS Chang, G Rabinowits, AA Thai, LA Dunn, BGM Hughes, NI Khushalani, B Modi, D Schadendorf, B Gao, F Seebach, S Li, et al.

Journal article  |  2018  |  New England Journal of Medicine

KEYNOTE-412: Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma

Lillian L Siu, Lisa Licitra, Yun Gan Tao, Chia-Jui Yen, Danny Rischin, John Waldron, Barbara Burtness, Vincent Gregoire, Sanjiv Agarwala, Jeffrey Yorio, Jean-Pierre DeLord, Sercan Aksoy, Sadakatsu Ikeda, Ruey-Long Hong, Joy Yang Ge, Holly Brown, Behzad Bidadi, Jean-Pascal Machiels

Conference Proceedings  |  2018  |  Clinical Trials

Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03

Michael Poulsen, David Macfarlane, Michael Veness, Venessa Estall, George Hruby, Mahesh Kumar, Andrew Pullar, Lee Tripcony, Danny Rischin

Journal article  |  2018  |  Journal of Medical Imaging and Radiation Oncology

A phase 3, randomized, open-label study of epacadostat plus pembrolizumab, pembrolizumab monotherapy, and the EXTREME regimen as first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma (R/M SCCHN): ECHO-304/KEYNOTE-669.

Ezra EW Cohen, Danny Rischin, David G Pfister, Jan Baptist Vermorken, Yufan Zhao, Hema Gowda, Joy Yang Ge, Fan Jin, Kevin J Harrington

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma: The phase 3 KEYNOTE-412 study.

Jean-Pascal H Machiels, Lisa F Licitra, Yungan Tao, Chia-Jui Yen, Danny Rischin, John Waldron, Barbara Burtness, Vincent Gregoire, Sanjiv S Agarwala, Jeffrey Yorio, Jean-Pierre Delord, Sercan Aksoy, Sadakatsu Ikeda, Ruey-Long Hong, Joy Yang Ge, Holly M Brown, Behzad Bidadi, Lillian L Siu

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

GOG 3016/ENGOT-cx9: An open-label, multi-national, randomized, phase 3 trial of cemiplimab, an anti-PD-1, versus investigator's choice (IC) chemotherapy in >= 2 line recurrent or metastatic cervical cancer.

Krishnansu Sujata Tewari, Ignace Vergote, Ana Oaknin, Edwin Alvarez, Dana Meredith Chase, Stephanie Gaillard, Stephanie Lheureux, Danny Rischin, Alessandro Santin, Minjie Feng, Melissa Mathias, Matthew G Fury, Israel Lowy, Bradley J Monk

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC)

Danny Rischin, Michael Robert Migden, Anne Chang, Christine H Chung, Lara Dunn, Alexander Guminski, Axel Hauschild, Leonel Hernandez-Aya, Brett Gordon Maxwell Hughes, Karl D Lewis, Annette May Ling Lim, Badri Modi, Dirk Schadendorf, Chrysalyne Schmults, Jocelyn Booth, Siyu Li, Kosalai Kal Mohan, Elizabeth Stankevich, Israel Lowy, Matthew G Fury

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition

Tania Moujaber, Dariush Etemadmoghadam, Catherine J Kennedy, Yoke-Eng Chiew, Rosemary L Balleine, Catherine Saunders, Gerard Wain, Bo Gao, Russell Hogg, Sivatharsny Srirangan, Casina Kan, Sian Fereday, Nadia Traficante, Ann-Marie Patch, John Pearson, Nicola Waddell, Sean M Grimmond, Alexander Dobrovic, David DL Bowtell, Paul R Harnett, et al.

Journal article  |  2018  |  JCO Precision Oncology

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial

Sandro Virgilio Porceddu, Mathias Bressel, Michael Geoffrey Poulsen, Adam Stoneley, Michael John Veness, Lizbeth Moira Kenny, Chris Wratten, June Corry, Stephen Cooper, Gerald Blaise Fogarty, Marnie Collins, Michael Kevin Collins, Andrew Martin John Macann, Christopher Gerard Milross, Michael Gordon Penniment, Howard Yu-hao Liu, Madeleine Trudy King, Benedict James Panizza, Danny Rischin

Journal article  |  2018  |  Journal of Clinical Oncology

High-Dose Cisplatin for Head and Neck Cancer Lives On

Alesha A Thai, Danny Rischin

Journal article  |  2018  |  Journal of Clinical Oncology

Prognostic Significance of PD-L1( ) and CD8( ) Immune Cells in HPV Oropharyngeal Squamous Cell Carcinoma

Benjamin Solomon, Richard J Young, Mathias Bressel, Damien Urban, Shona Hendry, Alesha Thai, Christopher Angel, Afaf Haddad, Marcin Kowanetz, Tsien Fua, June Corry, Stephen Fox, Danny Rischin

Journal article  |  2018  |  Cancer Immunology Research

The Clinical Impact of Hypoxia in Head and Neck Squamous Cell Carcinoma

Annette M Lim, Le Quynh-Thu, Danny Rischin

Book Chapter  |  2018

The role of human papillomavirus in p16-positive oral cancers

Simone Belobrov, Alyssa M Cornall, Richard J Young, Kendrick Koo, Christopher Angel, David Wiesenfeld, Danny Rischin, Suzanne M Garland, Michael McCullough

Journal article  |  2018  |  Journal of Oral Pathology & Medicine

KEYNOTE-412: Phase 3 trial of pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

CJ Yen, JP Machiels, L Licitra, D Rischin, J Waldron, B Burtness, V Gregoire, Y Tao, J Yorio, S Aksoy, S Ikeda, RL Hong, JY Ge, H Brown, B Bidadi, L Siu

Journal article  |  2017  |  Annals of Oncology

Formation of an international intergroup to coordinate clinical trials in head and neck cancers: HNCIG

Thu Le Quynh, John J Welch, Jan B Vermorken, Danny Rischin, Hisham Mehanna

Journal article  |  2017  |  Oral Oncology

Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin

June Corry, Mathias Bressel, Tsien Fua, Alan Herschtal, Benjamin Solomon, Sandro V Porceddu, Chris Wratten, Danny Rischin

Journal article  |  2017  |  International Journal of Radiation Oncology*Biology*Physics

KEYNOTE-412: Pembrolizumab (pembro) in combination with chemoradiation versus chemoradiation alone in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).

Jean-Pascal H Machiels, Lisa Licitra, Danny Rischin, John Waldron, Barbara Burtness, Vincent Gregoire, Tulin Shekar, Holly M Brown, Jonathan D Cheng, Lillian L Siu

Conference Proceedings  |  2017  |  Journal of Clinical Oncology

Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition

George Au-Yeung, Franziska Lang, Walid J Azar, Chris Mitchell, Kate E Jarman, Kurt Lackovic, Diar Aziz, Carleen Cullinane, Richard B Pearson, Linda Mileshkin, Danny Rischin, Alison M Karst, Ronny Drapkin, Dariush Etemadmoghadam, David DL Bowtell

Journal article  |  2017  |  Clinical Cancer Research

Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 ( HeadSTART)

Jolie Ringash, Richard Fisher, Lester Peters, Andy Trotti, Brian O'Sullivan, June Corry, Lizbeth Kenny, Walter Van Den Bogaert, Chris Wratten, Danny Rischin

Journal article  |  2017  |  International Journal of Radiation Oncology*Biology*Physics

Individualised mindfulness-based stress reduction for head and neck cancer patients undergoing radiotherapy of curative intent: a descriptive pilot study

A Pollard, JL Burchell, D Castle, K Neilson, M Ftanou, J Corry, D Rischin, DW Kissane, M Krishnasamy, LE Carlson, J Couper

Journal article  |  2017  |  European Journal of Cancer Care

Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation

Yada Kanjanapan, Siddhartha Deb, Richard J Young, Mathias Bressel, Linda Mileshkin, Danny Rischin, Michael S Hofman, Kailash Narayan, Shankar Siva

Journal article  |  2017  |  Clinical and Translational Radiation Oncology

Timely initiation of chemotherapy: a systematic literature review of six priority cancers - results and recommendations for clinical practice

M Alexander, R Blum, K Burbury, J Coutsouvelis, M Dooley, O Fazil, T Griffiths, H Ismail, S Joshi, N Love, S Opat, P Parente, N Porter, E Ross, J Siderov, P Thomas, S White, S Kirsa, D Rischin

Journal article  |  2017  |  Internal Medicine Journal

Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)

Jerome Fayette, Lori Wirth, Cristina Oprean, Anghel Udrea, Antonio Jimeno, Danny Rischin, Christopher Nutting, Paul M Harari, Tibor Csoszi, Dana Cernea, Paul O'Brien, William D Hanley, Amy V Kapp, Maria Anderson, Elicia Penuel, Bruce McCall, Andrea Pirzkall, Jan B Vermorken

Journal article  |  2016  |  Frontiers in Oncology

Guidelines for timely initiation of chemotherapy: a proposed framework for access to medical oncology and haematology cancer clinics and chemotherapy services

M Alexander, R Beattie-Manning, R Blum, J Byrne, C Hornby, C Kearny, N Love, J McGlashan, S McKiernan, JL Milar, D Murray, S Opat, P Parente, J Thomas, N Tweddle, C Underhill, K Whitfield, S Kirsa, D Rischin

Journal article  |  2016  |  Internal Medicine Journal

Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas

Annette M Lim, Nicholas C Wong, Ruth Pidsley, Elena Zotenko, June Corry, Alexander Dobrovic, Susan J Clark, Danny Rischin, Benjamin Solomon

Journal article  |  2016  |  Clinical Epigenetics

Recent Insights and Advances in the Management of Merkel Cell Carcinoma

Patricia D Banks, Shahneen Sandhu, David E Gyorki, Meredith L Johnston, Danny Rischin

Journal article  |  2016  |  Journal of Oncology Practice

p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary

Lachlan J McDowell, Richard J Young, Meredith L Johnston, Tze-Jian Tan, Stephen Kleid, Chen S Liu, Mathias Bressel, Vanessa Estall, Danny Rischin, Benjamin Solomon, June Corry

Journal article  |  2016  |  Cancer

PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

Danny Rischin, David R Spigel, Douglas Adkins, Richard Wein, Susanne Arnold, Nimit Singhal, Oliver Lee, Swami Murugappan

Journal article  |  2016  |  Head & Neck

Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinoma

Damien Urban, June Corry, Ben Solomon, Annette M Lim, Tsien Fua, Andrew Coleman, Ieta D'Costa, Albert Tiong, Chen Liu, Lester J Peters, Danny Rischin

Journal article  |  2016  |  Head & Neck

Quantitative and qualitative analysis of [F-18]FDG and [F-18]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome

Edward E Graves, Rodney J Hicks, David Binns, Mathias Bressel, Le Quynh-Thu, Lester Peters, Richard J Young, Danny Rischin

Journal article  |  2016  |  European Journal of Nuclear Medicine and Molecular Imaging

Oral cyclophosphamide in recurrent ovarian cancer

Despina Handolias, Michael Quinn, Serene Foo, Linda Mileshkin, Peter Grant, Gaelle Dutu, Danny Rischin

Journal article  |  2016  |  Asia-Pacific Journal of Clinical Oncology

BRAF Inhibition in BRAF(V600E)-Positive Anaplastic Thyroid Carcinoma

Annette M Lim, Graham R Taylor, Andrew Fellowes, Laird Cameron, Belinda Lee, Rodney J Hicks, Grant A McArthur, Christopher Angel, Benjamin Solomon, Danny Rischin

Journal article  |  2016  |  Journal of the National Comprehensive Cancer Network

F-18-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data

Shankar Siva, Siddhartha Deb, Richard J Young, Rodney J Hicks, Jason Callahan, Mathias Bressel, Linda Mileshkin, Danny Rischin, David Bernshaw, Kailash Narayan

Journal article  |  2015  |  European Journal of Nuclear Medicine and Molecular Imaging

Overview of Advances in Head and Neck Cancer

Danny Rischin, Robert L Ferris, Le Quynh-Thu

Journal article  |  2015  |  Journal of Clinical Oncology

Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs

Francis W Hunter, Richard J Young, Zvi Shalev, Ravi N Vellanki, Jingli Wang, Yongchuan Gu, Naveen Joshi, Sreevalsan Sreebhavan, Ilan Weinreb, David P Goldstein, Jason Moffat, Troy Ketela, Kevin R Brown, Marianne Koritzinsky, Benjamin Solomon, Danny Rischin, William R Wilson, Bradly G Wouters

Journal article  |  2015  |  Cancer Research

Ovarian Growing Teratoma Syndrome With Spuriously Elevated alpha-Fetoprotein

Adam Pendlebury, Danny Rischin, Kerryn Ireland-Jenkin, Guy C Toner, Peter Grant

Journal article  |  2015  |  Journal of Clinical Oncology

Safety and cost analysis of an (18)FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation

Ketan Shah, Luc te Marvelde, Marnie Collins, Richard De Abreu Lourenco, Ieta D'Costa, Andrew Coleman, Tsien Fua, Chen Liu, Danny Rischin, Eddie Lau, June Corry

Journal article  |  2015  |  Oral Oncology

Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma

RJ Young, D Urban, C Angel, J Corry, B Lyons, N Vallance, S Kleid, TA Iseli, B Solomon, D Rischin

Journal article  |  2015  |  British Journal of Cancer

MOLECULAR INSIGHTS INFLUENCING THE MANAGEMENT OF HEAD AND NECK CANCERS

Annette Lim, Benjamin Solomon, Danny Rischin

Journal article  |  2015  |  Cancer Forum

Abiraterone in Metastatic Salivary Duct Carcinoma

Damien Urban, Danny Rischin, Christopher Angel, Ieta D'Costa, Benjamin Solomon

Journal article  |  2015  |  Journal of the National Comprehensive Cancer Network

Impact of Center Size and Experience on Outcomes in Head and Neck Cancer

June Corry, Lester J Peters, Danny Rischin

Journal article  |  2015  |  Journal of Clinical Oncology

Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis

Senthil M Lingaratnam, Monica A Slavin, Karin A Thursky, Benjamin W Teh, Gabrielle M Haeusler, John F Seymour, Danny Rischin, Leon J Worth

Journal article  |  2015  |  Leukemia & Lymphoma

Merkel cell carcinoma: emerging biology, current approaches, and future directions.

Richard Tothill, Vanessa Estall, Danny Rischin

Journal article  |  2015  |  American Society of Clinical Oncology Educational Book

Merkel cell carcinoma (MCC) is an aggressive neuroendocrine cutaneous cancer that predominantly occurs in patients who are older, ..

Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome

Annette M Lim, Ida LM Candiloro, Nicholas Wong, Marnie Collins, Hongdo Do, Elena A Takano, Christopher Angel, Richard J Young, June Corry, David Wiesenfeld, Stephen Kleid, Elizabeth Sigston, Bernard Lyons, Danny Rischin, Benjamin Solomon, Alexander Dobrovic

Journal article  |  2014  |  Clinical Epigenetics

Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome

Annette M Lim, Hongdo Do, Richard J Young, Stephen Q Wong, Christopher Angel, Marnie Collins, Elena A Takano, June Corry, David Wiesenfeld, Stephen Kleid, Elizabeth Sigston, Bernard Lyons, Stephen B Fox, Danny Rischin, Alexander Dobrovic, Benjamin Solomon

Journal article  |  2014  |  International Journal of Cancer

What Is the Best Treatment for Patients With Human Papillomavirus-Positive and-Negative Oropharyngeal Cancer?

Damien Urban, June Corry, Danny Rischin

Journal article  |  2014  |  Cancer

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer

Bo Gao, Amanda Russell, Jonathan Beesley, Xiao Qing Chen, Sue Healey, Michelle Henderson, Mark Wong, Catherine Emmanuel, Laura Galletta, Sharon E Johnatty, David Bowtell, Michelle Haber, Murray Norris, Paul Harnett, Georgia Chenevix-Trench, Rosemary L Balleine, Anna deFazio

Journal article  |  2014  |  SCIENTIFIC REPORTS

Tonsillar cancer: The Peter MacCallum experience with unilateral and bilateral irradiation

Chen Liu, Gaelle Dutu, Lester J Peters, Danny Rischin, June Corry

Journal article  |  2014  |  Head & Neck

Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer

Mateya E Trinkaus, Rodney J Hicks, Richard J Young, Lester J Peters, Ben Solomon, Mathias Bressel, June Corry, Richard Fisher, David Binns, Grant A McArthur, Danny Rischin

Journal article  |  2014  |  Journal of Medical Imaging and Radiation Oncology

T4 squamous cell carcinoma of the oral tongue without mandibular involvement: surgery or chemoradiotherapy?

Lachlan McDowell, Marnie Collins, Stephen Kleid, Danny Rischin, June Corry

Journal article  |  2014  |  Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1-Amplified Ovarian Cancer

Dariush Etemadmoghadam, George Au-Yeung, Meaghan Wall, Chris Mitchell, Maya Kansara, Elizabeth Loehrer, Crisoula Batzios, Joshy George, Sarah Ftouni, Barbara A Weir, Scott Carter, Irma Gresshoff, Linda Mileshkin, Danny Rischin, William C Hahn, Paul M Waring, Gad Getz, Carleen Cullinane, Lynda J Campbell, David D Bowtell

Journal article  |  2013  |  CLINICAL CANCER RESEARCH

Dosing of cytotoxic chemotherapy: impact of renal function estimates on dose

MJ Dooley, SG Poole, D Rischin

Journal article  |  2013  |  Annals of Oncology

Suboptimal health literacy in patients with lung cancer or head and neck cancer

Kelvin Koay, Penelope Schofield, Karla Gough, Rachelle Buchbinder, Danny Rischin, David Ball, June Corry, Richard H Osborne, Michael Jefford

Journal article  |  2013  |  Supportive Care in Cancer

Imaging of hypoxia with F-18-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy

Mateya E Trinkaus, Rob Blum, Danny Rischin, Jason Callahan, Mathias Bressel, Tatiana Segard, Peter Roselt, Peter Eu, David Binns, Michael P MacManus, David Ball, Rodney J Hicks

Journal article  |  2013  |  Journal of Medical Imaging and Radiation Oncology

Developing a performance data suite to facilitate lean improvement in a chemotherapy day unit.

Senthil Lingaratnam, Danielle Murray, Amber Carle, Sue W Kirsa, Rebecca Paterson, Danny Rischin

Journal article  |  2013  |  Journal of Oncology Practice

PURPOSE: A multidisciplinary team from the Peter MacCallum Cancer Centre in Melbourne, Australia, developed a performance data sui..

Frequency of Fibroblast Growth Factor Receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome

Richard J Young, Annette M Lim, Christopher Angel, Marnie Collins, Siddhartha Deb, June Corry, David Wiesenfeld, Stephen Kleid, Elizabeth Sigston, Bernard Lyons, Prudence A Russell, Gavin Wright, Grant A McArthur, Stephen B Fox, Danny Rischin, Benjamin Solomon

Journal article  |  2013  |  Oral Oncology

Treatment response in the neck: p16 versus p16-oropharyngeal cancer

Daisy Mak, Rodney J Hicks, Danny Rischin, Ben Solomon, Lester Peters, Mathias Bressel, Richard J Young, June Corry

Journal article  |  2013  |  Journal of Medical Imaging and Radiation Oncology

A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma

Annette M Lim, June Corry, Marnie Collins, Lester Peters, Rodney J Hicks, Ieta D'Costa, Andrew Coleman, Margaret Chua, Benjamin Solomon, Danny Rischin

Journal article  |  2013  |  Oral Oncology

The Impact of Preradiation Residual Disease Volume on Time to Locoregional Failure in Cutaneous Merkel Cell Carcinoma-A TROG Substudy

Renee Finnigan, George Hruby, Chris Wratten, Jacqui Keller, Lee Tripcony, Graeme Dickie, Danny Rischin, Michael Poulsen

Journal article  |  2013  |  International Journal of Radiation: Oncology - Biology - Physics

Larynx Preservation for Patients With Locally Advanced Laryngeal Cancer

June Corry, Lester Peters, Stephen Kleid, Danny Rischin

Journal article  |  2013  |  Journal of Clinical Oncology

Radiation with cisplatin or carboplatin for locally advanced cervix cancer: The experience of a tertiary cancer centre

George Au-Yeung, Linda Mileshkin, David M Bernshaw, Srinivas Kondalsamy-Chennakesavan, Danny Rischin, Kailash Narayan

Journal article  |  2013  |  Journal of Medical Imaging and Radiation Oncology

Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study

Michael Boyer, Keith Horwood, Nick Pavlakis, Paul De Souza, Michael Millward, Brian Stein, Michael Johnston, Fiona Abell, Danny Rischin

Journal article  |  2012  |  Asia-Pacific Journal of Clinical Oncology

Correlation of Ataxia-Telangiectasia-Mutated (ATM) gene loss with outcome in head and neck squamous cell carcinoma

Annette M Lim, Richard J Young, Marnie Collins, Stephen B Fox, Grant A McArthur, June Corry, Lester Peters, Danny Rischin, Benjamin Solomon

Journal article  |  2012  |  Oral Oncology

Elusive Goal of Targeting Tumor Hypoxia for Therapeutic Gain

Lester Peters, Danny Rischin

Journal article  |  2012  |  Journal of Clinical Oncology

Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors

Jeffrey R Infante, D Ross Camidge, Linda R Mileshkin, Eric X Chen, Rodney J Hicks, Danny Rischin, Howard Fingert, Kristen J Pierce, Huiping Xu, W Gregory Roberts, S Martin Shreeve, Howard A Burris, Lillian L Siu

Journal article  |  2012  |  Journal of Clinical Oncology

Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer

Le Quynh-Thu, Richard Fisher, Kelly S Oliner, Richard J Young, Hongbin Cao, Christina Kong, Edward Graves, Rodney J Hicks, Grant A McArthur, Lester Peters, Brian O'Sullivan, Amato Giaccia, Danny Rischin

Journal article  |  2012  |  Clinical Cancer Research

Progress in Molecular Targeted Therapy for Thyroid Cancer: Vandetanib in Medullary Thyroid Cancer

Benjamin Solomon, Danny Rischin

Journal article  |  2012  |  Journal of Clinical Oncology

Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial

Annette M Lim, Danny Rischin, Richard Fisher, Hongbin Cao, Kathleen Kwok, Daniel Truong, Grant A McArthur, Richard J Young, Amato Giaccia, Lester Peters, Quynh-Thu Le

Journal article  |  2012  |  Clinical Cancer Research

Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma

D Mak, J Corry, E Lau, D Rischin, RJ Hicks

Journal article  |  2011  |  Quarterly Journal of Nuclear Medicine and Molecular Imaging

Carboplatin Dosing in Ovarian Cancer Problems and Pitfalls

Ian M Collins, Rachel Roberts-Thomson, David Faulkner, Danny Rischin, Michael Friedlander, Linda Mileshkin

Journal article  |  2011  |  International Journal of Gynecological Cancer

Cost-Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Solid Tumors

Fiona L Day, Jonathan Karnon, Danny Rischin

Journal article  |  2011  |  Journal of Clinical Oncology

Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation

Danny Rischin, David C Bibby, Geoff Chong, Gabriel Kremmidiotis, Annabell F Leske, Clayton A Matthews, Shirley S Wong, Mark A Rosen, Jayesh Desai

Journal article  |  2011  |  Clinical Cancer Research

Relationship between Epidermal Growth Factor Receptor Status, p16(INK4A), and Outcome in Head and Neck Squamous Cell Carcinoma

Richard J Young, Danny Rischin, Richard Fisher, Grant A McArthur, Stephen B Fox, Lester J Peters, June Corry, Annette Lim, Kelly Waldeck, Benjamin Solomon

Journal article  |  2011  |  Cancer Epidemiology, Biomarkers & Prevention

Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists.

Fiona L Day, Emma Link, Karin Thursky, Danny Rischin

Journal article  |  2011  |  Journal of Oncology Practice

PURPOSE: Universal screening for chronic hepatitis B virus (HBV) before chemotherapy has been recommended by the Centers for Disea..

IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

Michael S Anglesio, Joshy George, Hagen Kulbe, Michael Friedlander, Danny Rischin, Charlotte Lemech, Jeremy Power, Jermaine Coward, Prue A Cowin, Colin M House, Probir Chakravarty, Kylie L Gorringe, Ian G Campbell, Aikou Okamoto, Michael J Birrer, David G Huntsman, Anna de Fazio, Steve E Kalloger, Frances Balkwill, C Blake Gilks, et al.

Journal article  |  2011  |  Clinical Cancer Research

Larynx preservation with primary non-surgical treatment for loco-regionally advanced larynx cancer

June Corry, Danny Rischin, Sue Cotton, Ieta D'Costa, Margaret Chua, Neil Vallance, Bernard Lyons, Stephen Kleid, Andrew Sizeland, Lester J Peters

Journal article  |  2011  |  Journal of Medical Imaging and Radiation Oncology

The utility of PET/CT in staging and assessment of treatment response of nasopharyngeal cancer

Alastair Law, Lester J Peters, Gaelle Dutu, Danny Rischin, Eddie Lau, Elizabeth Drummond, June Corry

Journal article  |  2011  |  Journal of Medical Imaging and Radiation Oncology

Prolonged Remission in a Patient With Nasopharyngeal Carcinoma With a Solitary Bone Metastasis

Annette Lim, June Corry, Eddie Lau, Danny Rischin

Journal article  |  2011  |  Journal of Clinical Oncology

Intraperitoneal distribution imaging in ovarian cancer patients

SJ Dawson, RJ Hicks, V Johnston, D Allen, T Jobling, M Quinn, D Rischin

Journal article  |  2011  |  Internal Medicine Journal

Induction chemotherapy in head and neck cancer: closer to an answer?

June Corry, Danny Rischin

Journal article  |  2011  |  Lancet Oncology

Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer

FL Day, T Leong, S Ngan, R Thomas, M Jefford, JR Zalcberg, D Rischin, J McKendick, AD Milner, J Di Iulio, A Matera, M Michael

Journal article  |  2011  |  British Journal of Cancer

Comparison of self-reported smoking status and physician-recorded smoking status among patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Mateya Trinkaus, June Corry, Danny Rischin

Journal article  |  2011  |  Radiotherapy and Oncology

A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer

Michael Friedlander, Kenneth C Hancock, Danny Rischin, Mark J Messing, Claude A Stringer, Gemma M Matthys, Bo Ma, Jeffrey P Hodge, Joanne J Lager

Journal article  |  2010  |  Gynecologic Oncology

Erlotinib in Advanced Non-small Cell Lung Cancer Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study

Martin Reck, Nico van Zandwijk, Cesare Gridelli, Zoltan Baliko, Danny Rischin, Simon Allan, Maciej Krzakowski, David Heigener

Journal article  |  2010  |  Journal of Thoracic Oncology

Phase 1 Study of Tirapazamine in Combination With Radiation and Weekly Cisplatin in Patients With Locally Advanced Cervical Cancer

Danny Rischin, Kailash Narayan, Amit M Oza, Linda Mileshkin, David Bernshaw, Jimin Choi, Rodney Hicks, Bev McClure, Anthony Fyles

Journal article  |  2010  |  International Journal of Gynecological Cancer

Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group

Danny Rischin, Lester J Peters, Brian O'Sullivan, Jordi Giralt, Richard Fisher, Kally Yuen, Andy Trotti, Jacques Bernier, Jean Bourhis, Jolie Ringash, Michael Henke, Lizbeth Kenny

Journal article  |  2010  |  Journal of Clinical Oncology

Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02

Lester J Peters, Brian O'Sullivan, Jordi Giralt, Thomas J Fitzgerald, Andy Trotti, Jacques Bernier, Jean Bourhis, Kally Yuen, Richard Fisher, Danny Rischin

Journal article  |  2010  |  Journal of Clinical Oncology

A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors

Michael B Jameson, Danny Rischin, Mark Pegram, John Gutheil, Adam V Patterson, William A Denny, William R Wilson

Journal article  |  2010  |  Cancer Chemotherapy and Pharmacology

Optimising the therapeutic ratio in head and neck cancer

June Corry, Lester J Peters, Danny Rischin

Journal article  |  2010  |  Lancet Oncology

PROSPECTIVE TRIAL TO EVALUATE STAGED NECK DISSECTION OR ELECTIVE NECK RADIOTHERAPY IN PATIENTS WITH CT-STAGED T1-2 NO SQUAMOUS CELL CARCINOMA OF THE ORAL TONGUE

Sinead Brennan, June Corry, Stephen Kleid, Sandro Porceddu, Kally Yuen, Danny Rischin, Lester J Peters

Journal article  |  2010  |  Head & Neck

Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Orpharyngeal Cancer Treated on TROG 02.02 Phase III Trial

DR Rischin, undefined Young, undefined Fisher, undefined Fox, undefined Le, LJP Peters, undefined Solomon, undefined Choi, undefined O'Sullivan, undefined McArthur, undefined Kenny

Journal article  |  2010  |  Journal of Clinical Oncology

Oropharyngeal Cancer, Human Papilloma Virus, and Clinical Trials

Danny Rischin

Journal article  |  2010  |  Journal of Clinical Oncology

High-Administered Activity In-111 Octreotide Therapy with Concomitant Radiosensitizing 5FU Chemotherapy for Treatment of Neuroendocrine Tumors: Preliminary Experience

Grace Kong, Val Johnston, Shakher Ramdave, Eddie Lau, Danny Rischin, Rodney J Hicks

Journal article  |  2009  |  Cancer Biotherapy & Radiopharmaceuticals

PROSPECTIVE STUDY OF PERCUTANEOUS ENDOSCOPIC GASTROSTOMY TUBES VERSUS NASOGASTRIC TUBES FOR ENTERAL FEEDING IN PATIENTS WITH HEAD AND NECK CANCER UNDERGOING (CHEMO)RADIATION

June Corry, Wendy Poon, Narelle McPhee, Alvin D Milner, Deborah Cruickshank, Sandro V Porceddu, Danny Rischin, Lester J Peters

Journal article  |  2009  |  Head & Neck

Phase III Study of Gefitinib 250 Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck

J Simon W Stewart, Ezra EW Cohen, Lisa Licitra, Carla ML Van Herpen, Chonlakiet Khorprasert, Denis Soulieres, Pavel Vodvarka, Danny Rischin, Avgust M Garin, Fred R Hirsch, Marileila Varella-Garcia, Serban Ghiorghiu, Laura Hargreaves, Alison Armour, Georgina Speake, Alan Swaisland, Everett E Vokes

Journal article  |  2009  |  Journal of Clinical Oncology

Sinonasal Malignancies of Neuroendocrine Origin

Danny Rischin, Andrew Coleman

Journal article  |  2008  |  Hematology / Oncology Clinics of North America

Long-term survival following chemoradiation for inoperable non-small cell lung cancer

Nikki M Plumridge, Michael J Millward, Danny Rischin, Michael P MacManus, Andrew Wirth, Michael Michael, Kally Yuen, David L Ball

Journal article  |  2008  |  Medical Journal of Australia

WEEKLY CARBOPLATIN REDUCES TOXICITY DURING SYNCHRONOUS CHEMORADIOTHERAPY FOR MERKEL CELL CARCINOMA OF SKIN

Michael Poulsen, Euan Walpole, Jennifer Harvey, Graeme Dickie, Peter O'Brien, Jacqui Keller, Lee Tripcony, Danny Rischin

Journal article  |  2008  |  International Journal of Radiation: Oncology - Biology - Physics

Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation

J Corry, W Poon, N McPhee, AD Milner, D Cruickshank, SV Porceddu, D Rischin, LJ Peters

Journal article  |  2008  |  Journal of Medical Imaging and Radiation Oncology

Sustained clinical responses to tyrosine kinase inhibitor sunitinib thyroid carcinoma

Sarah-Jane Dawson, Nelly Marmy Conus, Guy C Toner, Jeanette M Raleigh, Rodney J Hicks, Grant McArthur, Danny Rischin

Journal article  |  2008  |  Anti-Cancer Drugs: international journal on anti-cancer agents

N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders - Results of Trans Tasman Radiation Oncology Group study 98.02

June Corry, Lester Peters, Richard Fisher, Andrew Macann, Michael Jackson, Bev McClure, Danny Rischin

Journal article  |  2008  |  Head & Neck

Clinical impact of, and prognostic stratification by, f-18 fdg pet/ct in head and neck mucosal squamous cell carcinoma

Caroline A Connell, June Corry, Alvin D Milner, Annette Hogg, Rodney J Hicks, Danny Rischin, Lester J Peters

Journal article  |  2007  |  Head & Neck

Hypoxia in Head and Neck Cancer: Studies With Hypoxic Positron Emission Tomography Imaging and Hypoxic Cytotoxins

Danny Rischin, Richard Fisher, Lester Peters, June Corry, Rodney Hicks

Journal article  |  2007  |  International Journal of Radiation: Oncology - Biology - Physics

How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT?

Guohui Wang, Eddie WF Lau, Ramdave Shakher, Danny Rischin, Robert E Ware, Emily Hong, David S Birms, Annette Hogg, Elizabeth Drummond, Rodney J Hicks

Journal article  |  2007  |  Cancer

Prognostic significance of [F-18]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncology Group study 98.02

D Rischin, RJ Hicks, R Fisher, D Binns, J Corry, S Porceddu, LJ Peters

Journal article  |  2006  |  Journal of Clinical Oncology

Hypocalcemia associated with bone metastases in a patient with salivary-gland carcinoma

SJ Dawson, RML Murray, D Rischin

Journal article  |  2006  |  Nature Clinical Practice Oncology

Does chemotherapy improve survival in high-risk Stage I and II Merkel cell carcinoma of the skin?

MG Poulsen, D Rischin, I Porter, E Walpole, J Harvey, C Hamilton, J Keller, L Tripcony

Journal article  |  2006  |  International Journal of Radiation: Oncology - Biology - Physics

Relapse patterns in WHO 2/3 nasopharyngeal cancer: Is there a difference between ethnic Asian vs. non-Asian patients?

J Corry, R Fisher, D Rischin, LJ Peters

Journal article  |  2006  |  International Journal of Radiation: Oncology - Biology - Physics

Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent

Rodney J Hicks, Danny Rischin, Richard Fisher, David Binns, Andrew M Scott, Lester J Peters

Journal article  |  2005  |  European Journal of Nuclear Medicine and Molecular Imaging

A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC

M Michael, A Wirth, DL Ball, M MacManus, D Rischin, L Mileshkin, B Solomon, J McKendrick, AD Milner

Journal article  |  2005  |  British Journal of Cancer

Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors

SN Holden, SG Eckhardt, R Basser, R de Boer, D Rischin, M Green, MA Rosenthal, C Wheeler, A Barge, HI Hurwitz

Journal article  |  2005  |  Annals of Oncology

Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801)

SYK Ngan, R Fisher, BH Burmeister, J Mackay, D Goldstein, A Kneebone, D Schache, D Joseph, J McKendrick, T Leong, B McClure, D Rischin

Journal article  |  2005  |  Diseases of the Colon and Rectum

Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure

MP Mac Manus, RJ Hicks, JP Matthews, A Wirth, D Rischin, DL Ball

Journal article  |  2005  |  Lung Cancer

The contribution of cytotoxic chemotherapy to the management of cancer

L Mileshkin, D Rischin, HM Prince, J Zalcberg

Journal article  |  2005  |  Clinical Oncology

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

RW Tothill, A Kowalczyk, D Rischin, A Bousioutas, I Haviv, RK van Laar, PM Waring, J Zalcberg, R Ward, AV Biankin, RL Sutherland, SM Henshall, K Fong, JR Pollack, DDL Bowtell, AJ Holloway

Journal article  |  2005  |  Cancer Research

The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin

CL Scott, I Kudaba, JM Stewart, RJ Hicks, D Rischin

Journal article  |  2005  |  Molecular Imaging and Biology

Results of treatment intensification for progressive locoregional disease in head-and-neck cancer patients undergoing postoperative radiotherapy

J Corry, D Rischin, BN Mukesh, S Porceddu, LJ Peters

Journal article  |  2005  |  International Journal of Radiation: Oncology - Biology - Physics

Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer

SV Porceddu, E Jarmolowski, RJ Hicks, R Ware, L Weih, D Rischin, J Corry, LJ Peters

Journal article  |  2005  |  Head & Neck

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial

S Loi, SYK Ngan, RJ Hicks, B Mukesh, P Mitchell, M Michael, J Zalcberg, T Leong, D Lim-Joon, J Mackay, D Rischin

Journal article  |  2005  |  British Journal of Cancer

Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)

D Rischin, L Peters, R Fisher, A Macann, J Denham, M Poulsen, M Jackson, L Kenny, M Penniment, J Corry, D Lamb, B McClure

Journal article  |  2005  |  Journal of Clinical Oncology

PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomy

KB Roberts, MP Mac Manus, RJ Hicks, D Rischin, A Wirth, GM Wright, DL Ball

Journal article  |  2005  |  Lung Cancer

Induction Chemotherapy in Head and Neck Cancer

D RISCHIN

Scholarly edition  |  2005

Strategies to overcome accelerated repopulation and hypoxia - What have we learned from clinical trials?

J Corry, D Rischin

Journal article  |  2004  |  Seminars in Oncology

Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for the head and neck

RE Ware, JP Matthews, RJ Hicks, S Porceddu, A Hogg, D Rischin, J Corry, LJ Peters

Journal article  |  2004  |  Head & Neck

A randomized cross-over trial to determine the effect of Cremophor EL on the pharmacodynamics and pharmacokinetics of carboplatin chemotherapy

S Loi, D Rischin, M Michael, K Yuen, K Stokes, AG Ellis, MJ Millward, LK Webster

Journal article  |  2004  |  Cancer Chemotherapy and Pharmacology

Early FDG-pet imaging after radical radiotherapy for non-small-cell lung cancer: Inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation

RJ Hicks, MP Mac Manus, JP Matthews, A Hogg, D Binns, D Rischin, DL Ball, LJ Peters

Journal article  |  2004  |  International Journal of Radiation: Oncology - Biology - Physics

Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma

SV Porceddu, B Campbell, D Rischin, J Corry, L Weih, M Guerrieri, M Grossi, LJ Peters

Journal article  |  2004  |  International Journal of Radiation: Oncology - Biology - Physics

'Boomerang' technique: an improved method for conformal treatment of locally advanced nasopharyngeal cancer.

June Corry, Colin Hornby, Richard Fisher, Ieta D'Costa, Sandro Porceddu, Danny Rischin, Lester J Peters

Journal article  |  2004  |  Australasian Radiology

The primary aim of the present study was to assess radiation dosimetry and subsequent clinical outcomes in patients with locally a..

Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma

D Rischin, S Porceddu, L Peters, J Martin, J Corry, L Weih

Journal article  |  2004  |  Head & Neck

A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer

D Rischin, KA Phillips, M Friedlander, P Harnett, M Quinn, G Richardson, A Martin

Journal article  |  2004  |  Gynecologic Oncology

Paranasal sinus tumors: Peter MacCallum Cancer Institute experience

S Porceddu, J Martin, G Shanker, L Weih, C Russell, D Rischin, J Corry, L Peters

Journal article  |  2004  |  Head & Neck

Impact of positron emission tomography on the management of patients with small-cell lung cancer - Preliminary experience

R Blum, MP MacManus, D Rischin, M Michael, D Ball, RJ Hicks

Journal article  |  2004  |  American Journal of Clinical Oncology - Cancer Clinical Trials

Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patients

MJ Dooley, S Singh, D Rischin

Journal article  |  2004  |  British Journal of Cancer

Intensity-modulated radiotherapy: examples of its utility in head and neck cancer.

Sandro Porceddu, Geoff Hope, Julie Wills, Jim Cramb, Danny Rischin, June Corry, Lester Peters

Journal article  |  2004  |  Australasian Radiology

Intensity-modulated radiotherapy (IMRT) has been available at Peter MaCallum Cancer Centre (PMCC) since November 2000. The present..

Merkel cell carcinoma - current therapeutic options

M Poulsen, D Rischin

Journal article  |  2003  |  Expert Opinion on Pharmacotherapy

Phase II study of imatinib in patients with small cell lung cancer

BE Johnson, T Fischer, B Fischer, D Dunlop, D Rischin, S Silberman, MO Kowalski, D Sayles, S Dimitrijevic, C Fletcher, J Hornick, R Salgia, T Le Chevalier

Journal article  |  2003  |  Clinical Cancer Research

High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: A Trans-Tasman Radiation Oncology Group Study - TROG 96 : 07

M Poulsen, D Rischin, E Walpole, J Harvey, J Mackintosh, J Ainslie, C Hamilton, J Keller, L Tripcony

Journal article  |  2003  |  Journal of Clinical Oncology

Promising New Approaches in the Treatment of Advanced Head and Neck Cancer

PM Harari, GK Hartig, D Rischin, LJ Peters

Journal article  |  2003  |  American Journal of Cancer

Comparison of neutropenia in a randomized, crossover trial of 3-, 6-, and 24-h infusions of paclitaxel

R Jennens, D Rischin, K Yuen, G Toner, M Millward

Journal article  |  2003  |  Gynecologic Oncology

Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer

B Solomon, DL Ball, G Richardson, JG Smith, M Millward, M MacManus, M Michael, A Wirth, C O'Kane, L Muceniekas, G Ryan, D Rischin

Journal article  |  2003  |  Lung Cancer

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer

M Fukuoka, S Yano, G Giaccone, T Tamura, K Nakagawa, JY Douillard, Y Nishiwaki, J Vansteenkiste, S Kudoh, D Rischin, R Eek, T Horai, K Noda, I Takata, E Smit, S Averbuch, A Macleod, A Feyereislova, RP Dong, J Baselga

Journal article  |  2003  |  Journal of Clinical Oncology

Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors

PM LoRusso, RS Herbst, D Rischin, M Ranson, H Calvert, E Raymond, D Kieback, S Kaye, L Gianni, A Harris, T Bjork, AM Maddox, ML Rothenberg, EJ Small, EH Rubin, A Feyereislova, A Heyes, SD Averbuch, J Ochs, J Baselga

Journal article  |  2003  |  Clinical Cancer Research

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

MP Mac Manus, RJ Hicks, JP Matthews, A McKenzie, D Rischin, EK Salminen, DL Ball

Journal article  |  2003  |  Journal of Clinical Oncology

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients

MJ Millward, MJ Boyer, M Lehnert, S Clarke, D Rischin, BC Goh, J Wong, E McNeil, JF Bishop

Journal article  |  2003  |  Annals of Oncology

The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor

GB Fogarty, LJ Peters, J Stewart, C Scott, D Rischin, RJ Hicks

Journal article  |  2003  |  Head & Neck

FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy - Survival correlates with metastatic disease burden

MP MacManus, R Hicks, R Fisher, D Rischin, M Michael, A Wirth, DL Ball

Journal article  |  2003  |  Acta Oncologica

Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia

MA Rosenthal, D Rischin, G McArthur, K Ribbons, B Chong, J Fareed, G Toner, MD Green, RL Basser

Journal article  |  2002  |  Annals of Oncology

Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer

D Rischin, L Peters, R Hicks, P Hughes, R Fisher, R Hart, M Sexton, I D'Costa, R von Roemeling

Journal article  |  2001  |  Journal of Clinical Oncology